Genexine, Inc. · KRX:095700

Genexine, Inc. financial statements

Genexine, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.57B2.93B4.43B16.1B36.8B18.5B11.3B12.9B28.5B11.4B
Cost of revenue4.96B4.17B4.04B4.78B5.02B6.87B3.85B6.33B10.7B4.78B
Gross profit-385.7M-1.24B387.5M11.4B31.8B11.7B7.45B6.55B17.8B6.57B
Research and development26.6B22.0B26.3B26.4B33.1B39.2B
Selling, general and administrative3.85B12.5B13.7B17.0B16.5B10.6B10.7B11.2B8.98B16.5B
Operating income-36.1B-36.9B-42.4B-34.5B-20.2B-46.6B-44.5B-38.2B-26.9B-30.9B
Depreciation and amortization7.03B4.37B4.63B4.87B3.30B2.92B2.50B1.65B2.03B2.21B
EBITDA-29.0B-32.6B-37.8B-29.6B-16.9B-43.7B-42.0B-36.5B-24.9B-28.7B
Interest expense2.44B2.65B4.11B3.31B492.4M2.92B0000
Income before tax-27.2B-65.4B-66.9B-57.1B-48.6B27.5B-16.5B-34.1B-19.3B-30.9B
Net income-27.2B-63.7B-66.9B-56.3B-47.7B27.6B-16.5B-34.1B-19.3B-30.9B
Earnings per share, basic-598.40-1,400.75-1,613.36-1,721.54-1,382.801,116.28-694.79-1,209.39-698.54-1,260.91

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents9.15B1.16B6.03B17.9B27.8B5.21B19.1B57.0B11.8B24.5B
Short-term investments25.8B30.9B58.5B4.00B01.50B63.5B115.3B36.9B
Receivables300.3M4.78B10.7B9.38B1.03B2.74B3.96B2.49B14.7B5.60B
Inventory3.12B3.81B12.0B7.17B128.6M
Current assets45.9B46.9B92.2B52.4B43.8B20.6B95.8B177.5B28.9B71.9B
Property, plant and equipment118.9B114.2B110.9B112.0B71.9B49.8B47.2B41.3B23.6B
Total assets371.3B345.0B376.6B388.8B636.9B596.9B358.2B374.8B140.7B198.7B
Current liabilities116.9B54.0B54.5B78.9B59.2B40.2B22.6B10.8B13.0B26.1B
Long-term debt6.56B27.1B22.7B18.5B40.6B15.8B28.9B34.6B11.5B0
Total debt26.0B29.2B34.6B14.5B
Total liabilities124.5B83.4B79.7B112.6B119.1B61.3B61.3B54.3B26.8B28.5B
Shareholders' equity246.8B261.7B296.6B276.2B517.7B535.6B296.9B320.5B113.9B170.2B
Shares outstanding45.5M45.5M41.4M32.7M34.5M24.7M23.8M28.2M27.7M24.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-29.6B-1.65B-38.1B-39.8B-12.7B-22.7B-41.6B-20.1B-26.1B-14.1B
Capital spending-14.8B-7.30B-7.38B-31.7B-56.4B-22.2B-3.96B-8.01B-20.5B-5.07B
Free cash flow-44.3B-8.95B-45.4B-71.6B-69.8B-46.8B-45.5B-28.1B-46.6B-19.2B
Cash from investing-11.2B-34.3B-1.92B-7.70B-64.4B1.64B-185.6B17.8B-53.6B
Cash from financing7.96B60.4B31.6B43.1B73.4B3.33B250.9B-3.64B81.1B
Share buybacks84.2B1.98B13.4B61.9B3.50B206.2B4.06B61.4B
Change in cash7.99B-4.87B-11.9B-9.85B22.6B-13.9B-36.6B45.2B-12.0B13.4B